QYBLANT Trademark

Trademark Overview

On Wednesday, April 17, 2013, a trademark application was filed for QYBLANT with the United States Patent and Trademark Office. The USPTO has given the QYBLANT trademark a serial number of 85906533. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 19, 2021. This trademark is owned by Sanofi. The QYBLANT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, insulin
qyblant

General Information

Serial Number85906533
Word MarkQYBLANT
Filing DateWednesday, April 17, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 19, 2021
Registration Number4582665
Registration DateTuesday, August 12, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, insulin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Trademark Events

Event DateEvent Description
Friday, March 19, 2021CANCELLED SEC. 8 (6-YR)
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 12, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 23, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 4, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 4, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 4, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 25, 2014NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, February 25, 2014INQUIRY TO SUSPENSION E-MAILED
Tuesday, February 25, 2014SUSPENSION INQUIRY WRITTEN
Monday, February 3, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, February 3, 2014ASSIGNED TO LIE
Wednesday, July 24, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 24, 2013LETTER OF SUSPENSION E-MAILED
Wednesday, July 24, 2013SUSPENSION LETTER WRITTEN
Wednesday, July 24, 2013ASSIGNED TO EXAMINER
Tuesday, April 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 20, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

qyblant insulin namely preparations pharmaceutical